News DexCom, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
127.4 ^USD	+1.41%		-3.04%	+2.64%

May. 24	Declaration of Voting Results by DexCom, Inc	CI
May. 24	Declaration of Voting Results by DexCom, Inc	CI

Declaration of Voting Results by DexCom, Inc	May. 24	CI
Declaration of Voting Results by DexCom, Inc	May. 24	CI
Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes	May. 20	BU
DexCom : Human Rights Statement	May. 08	PU
Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	Apr. 30	CI
Wall Street: the worst week of 2024 is followed by the best	Apr. 26	CF
Morgan Stanley Adjusts DexCom's Price Target to $132 From $122	Apr. 26	MT
Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144	Apr. 26	MT
Raymond James Adjusts DexCom Price Target to $160 From $151	Apr. 26	MT
Dexcom's profit beats estimates on strong glucose monitor demand	Apr. 25	RE
DexCom, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours	Apr. 25	MT
Transcript : DexCom, Inc., Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27	Apr. 25	MT
Earnings Flash (DXCM) DEXCOM Posts Q1 Revenue $921M, vs. Street Est of $910.9M	Apr. 25	MT
DexCom: Q1 Earnings Snapshot	Apr. 25	AQ
Dexcom Reports First Quarter 2024 Financial Results	Apr. 25	BU
DexCom, Inc. Provides Earnings Guidance for the Year 2024	Apr. 25	CI
John Chevedden Submits a Shareholder Proposal to DexCom	Apr. 22	CI
Myra K. Young Submits a Shareholder Proposal to DexCom	Apr. 22	CI

No results for this search

DexCom is still in the running

March 07, 2024 at 04:49 am EST